Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Sevelamer Hydrochloride

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Sevelamer Hydrochloride

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 115Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Navinta`s Generics Sevelamer HCl Receives Approval in US
    Navinta`s Generics Sevelamer HCl Receives Approval in US

    03 Feb 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218966

    FDA
    03 Feb 2025
    Share Share
    Strides receives USFDA approval for Sevelamer Carbonate Tablets
    Strides receives USFDA approval for Sevelamer Carbonate Tablets

    10 May 2024

    // PRESS RELEASE

    https://strides.com/pdf/pressrelease/2024/StridesSEIntimation_10May24.pdf

    PRESS RELEASE
    10 May 2024
    Share Share
    Aurobindo's Generic Sevelamer Hydrochloride Receives Approval in the U.S.
    Aurobindo's Generic Sevelamer Hydrochloride Receives Approval in the U.S.

    11 Jul 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212599

    FDA
    11 Jul 2023
    Share Share
    We are glad to share that the US DMF for Sevelamer Hydrochloride was successfully submitted to the USFDA. We have a distinctive advantage
    We are glad to share that the US DMF for Sevelamer Hydrochloride was successfully submitted to the USFDA. We have a distinctive advantage

    02 Mar 2023

    // PRESS RELEASE

    https://amilifesciences.com/media.php

    PRESS RELEASE
    02 Mar 2023
    Share Share
    Unicycive's pivotal trial of Takeda kidney drug rival hits goal
    Unicycive's pivotal trial of Takeda kidney drug rival hits goal

    04 Jan 2023

    // Nick Paul Taylor FIERCE PHARMA

    https://www.fiercepharma.com/pharma/unicycives-pivotal-trial-rival-takeda-kidney-drug-hits-main-goal-clearing-path-fda-filing

    Nick Paul Taylor FIERCE PHARMA
    04 Jan 2023
    Share Share
    Lupin launches generic medication in US market
    Lupin launches generic medication in US market

    01 Mar 2022

    // ECONOMIC TIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/lupin-launches-generic-medication-in-us-market/articleshow/89924486.cms

    ECONOMIC TIMES
    01 Mar 2022
    Share Share